Ro.co vs Dr. House: Compare GLP-1 Programs & Pricing
Side-by-side Ro.co and Dr. House: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Ro.co and Dr. House are telehealth providers that connect patients with clinicians for GLP-1–based weight-management and metabolic care. This comparison summarizes how each service handles clinical intake, pricing transparency, membership requirements, and patient support so you can decide which fits your needs.
Ro.co vs Dr. House: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Ro.co | Not publicly listed | Not publicly listed | Brand med access | $145.00 — Yes |
| Dr. House | Not publicly listed | Not publicly listed | — | — No |
Both platforms operate across many U.S. states and rely on licensed clinicians to evaluate eligibility for GLP-1 or related peptide therapies. Availability of specific formulations, branded products, and compounding options varies by state and pharmacy.
Ro.co vs Dr. House: Medical Process & Accessibility
Ro.co typically emphasizes streamlined intake with a focus on rapid clinician review and prescription fulfillment. Their model suits users who prioritize convenience and quick onboarding. Clinical assessments follow telehealth protocols and include medical history, medication review, and risk screening.
Dr. House offers a telehealth pathway that highlights structured follow-ups and individualized dose adjustments. Patients report more frequent clinician touchpoints aimed at titration and symptom management. Both providers require clinician approval before any prescription is sent to a partnering pharmacy.
Ro.co vs Dr. House: Pricing Comparison
Neither provider publishes consistent nationwide list pricing for semaglutide or tirzepatide on all plans, as costs depend on formulation, dose, pharmacy, and local regulations. Where public starting prices are not displayed, expect to see price variations based on compounded versus branded prescriptions and monthly supply size.
Important pricing notes: Ro.co lists a $145.00 membership fee for access to its program; Dr. House does not require a recurring membership fee. Ro.co lists a promo labeled “Brand med access.” Confirm any promotional codes, first-fill discounts, or membership waivers directly on each provider’s site before enrolling.
Ro.co vs Dr. House: Clinical Oversight & Support
Both services use licensed clinicians to evaluate safety, contraindications, and appropriate dosing. Telehealth clinicians will assess cardiovascular history, pregnancy potential, pancreatitis risk, and other conditions that may affect suitability for GLP-1 or dual agonist therapy.
Follow-up schedules vary: some patients receive weekly or biweekly check-ins during titration, while others have monthly monitoring. If side effects occur (nausea, vomiting, or signs of pancreatitis), clinicians will modify therapy or advise discontinuation as needed.
Ro.co vs Dr. House: Medication Quality & Safety
Dispensing is typically handled by U.S.-based pharmacies working under clinician prescription. Some clinics offer compounded formulations; others may access branded, FDA-approved products where available. Patients should ask whether a prescription is for an FDA-approved branded agent or a compounded alternative and understand the differences in labeling, manufacturing, and insurance coverage.
View Dr. House Medication Info
Ro.co vs Dr. House: Final Verdict
Choose Ro.co if you prefer a membership-based program with a $145.00 access fee and faster onboarding. Choose Dr. House if you prefer no membership requirement and an emphasis on structured follow-up and dose management. Both providers are credible telehealth options; the best choice depends on your priorities for cost, clinician contact, and medication sourcing.
Join Ro.co
Get Started with Dr. House
Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP1Talks & GLP1Discussions may receive affiliate commissions at no cost to you. Telehealth clinicians determine medical eligibility and dosing; always consult a licensed clinician before starting or changing any medication. For questions about FDA approvals and on-label uses, refer to official FDA resources or speak with your prescribing clinician.